The Sanger sequencing service market size is projected to reach US$ 2,292.71 million by 2031 from US$ 841.62 million in 2023. The market is expected to register a CAGR of 13.3% during 2023–2031. Increasing number for Next-generation Sequencing and adoption of automation and robotics are likely to remain key trends in the market.
The sanger sequencing service market is driven by increasing research and development in genomics including genomic sequencing gene expression profiling, genetic variation analysis. Sanger sequencing remains a valued tool for validation of NGS data, targeted gene sequencing, and other specific genomics research applications. Additionally, increasing adoption of clinical diagnostics and personalized medicine is also expected to contribute to the market growth. Sanger sequencing plays an important role in clinical diagnostics for identifying genetic mutations associated with genetic disorders, cancer, and other disorders. Moreover, the surging adoption of personalized medicine and the need for precise genetic testing are contributing to the market growth. However, increasing use of sanger sequencing services in emerging economies is expected to create ample opportunities for the market growth in coming years.
Sanger sequencing services market is expected to register the significant growth rate owing to the increase in research and development in genomics, clinical diagnostics, personalized medicine and others along with increasing number of service providers globally. Additionally, increasing use of sanger sequencing services in emerging economies is expected to create opportunities in coming years. The biomarkers and cancer application areas segment accounts for the largest market share owing to the surging incidence of cancer, increasing research on cancer biomarkers and increasing use of cancer biomarkers in drug discovery and diagnostics. Furthermore, In 2023, North America accounts for largest share in global Sanger sequencing service market and was projected to have highest market share over the forecast period. The growth of the Sanger sequencing service market in this region is primarily driven by the increasing cancer research, funding’s and developments for genomics and precision medicine. However, Asia Pacific is the fastest growing region owing to growing research activities and increasing presence of major market player are driving growth in the Asia Pacific region.
Sanger sequencing service-providing companies are expanding their global reach to the market and also playing a significant role in increasing the adaptability of sequencing technologies across the globe. For instance, In June 2023, Source Genomics, a part of the Source BioScience group opened new laboratory in the North of England. This will provide Source Genomics industry-leading Sanger Sequencing service to the northern territory with faster turnaround times for optimized data delivery.
Moreover, in recent years, the CRISPR-Cas9 system has been established as the editing technique in complex organisms. This system is greatly considered as a choice due to advantages offered by it, such as cost-effectiveness, ease of use, and the high efficacy of desired targeted edits. However, in genome editing experiments, the repair process is not completely accurate; therefore, fragment analysis or Sanger sequencing by capillary electrophoresis (CE) are used to determine the efficiency of CRISPR-mediated genome editing in primary transformed cell cultures. Additionally, Sanger sequencing is also used to determine successful editing events in secondary clones. Thus, the growing usage of Sanger sequencing in different application will propel the Sanger sequencing service market.
The emerging markets in the developing countries in the Asia Pacific region are creating better opportunities for the major market players to expand their business. Most of the major players focus on emerging markets such as India, China, and others. As they have a large population and technological advancements in these countries also favor the growth of the market.
Furthermore, the growing healthcare sector in this region is likely to enhance the growth opportunities for the prenatal and newborn genetic testing market. For instance, the increasing number of corporate hospitals like Apollo group, Max, Fortis, and others in India is likely increasing professionalism as well as lead to the emergence of the latest medical technology. The Max Healthcare offers the prenatal test in India in order to identify as well as prevent the genetic disability in the newborn.
Thus, the growing population in emerging countries and advanced healthcare sector in the region is likely to boost the market and is expected to provide significant growth opportunities to the players operating in the market during the forecast period.
Key segments that contributed to the derivation of the Sanger sequencing service market analysis are application and end user.
The geographic scope of the Sanger sequencing service market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the sanger sequencing service market and is estimated to have a larger share in the United States. The growth of the Sanger sequencing service market in the United States is expected to grow owing to rising applications of the Sanger sequencing. Molecular profiling of cancers is very crucial in personalized cancer therapy, or precision oncology. Sanger sequencing enables detection of low-level variant in the given sample with minimal amounts of DNA, such as formalin-fixed paraffin-embedded (FFPE) tissues. Thus, growing cancer prevalence in US is likely to demand for Sanger sequencing services. The National Cancer Institute estimated that in 2018, approximately 1,735,350 new cases of cancer will be diagnosed in the US. Furthermore, Sanger sequencing is used for confirming the sequence variants identified by Next Generation Sequencing. Thus, growing adoption of NGS in diagnostic laboratories and research institutes is likely to favor market growth. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Sanger Sequencing Service Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Sanger Sequencing Service Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 841.62 Million |
| Market Size by 2031 | US$ 2,292.71 Million |
| Global CAGR (2023 - 2031) | 13.3% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Application
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Sanger Sequencing Service Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Sanger Sequencing Service Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Sanger sequencing service market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Sanger sequencing service market are listed below:
The “Sanger Sequencing Service Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
In terms of market share, North America region has dominated the Sanger sequencing service market in 2023
The driving factors impacting the Sanger sequencing service market includes increase in research and development in genomics, clinical diagnostics, personalized medicine and others along with increasing number of service providers globally
Increasing number for Next-generation Sequencing and adoption of automation and robotics are the future trends of the Sanger sequencing service market
The leading players operating in the Sanger sequencing service market includes Microsynth AG, Laragen, Inc., StarSEQ GmbH, Thermo Fisher Scientific, Inc., LGC Biosearch Technologies, Fasteris SA, Quintara Biosciences, GENEWIZ, GenScript, and SciGenom Labs among others
The estimated value of the Sanger sequencing service market by the end of 2031 is US$ 2,292.71 Mn
The expected CAGR of the Sanger sequencing service market form 2023- 2031 is 13.3%